GYRE THERAPEUTICS, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Gyre Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Gyre Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -302 %, a 46.3% increase year-over-year.
  • Gyre Therapeutics, Inc. annual Return On Equity for 2023 was 514 %, a 5199% increase from 2022.
  • Gyre Therapeutics, Inc. annual Return On Equity for 2022 was 9.69 %.
  • Gyre Therapeutics, Inc. annual Return On Equity for 2021 was -121 %, a 102% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 514 +504 +5199% Jan 1, 2023 Dec 31, 2023
2022 9.69 +131 Jan 1, 2022 Dec 31, 2022
2021 -121 -61.1 -102% Jan 1, 2021 Dec 31, 2021
2020 -59.7 +3.59 +5.67% Jan 1, 2020 Dec 31, 2020
2019 -63.3 -40.6 -179% Jan 1, 2019 Dec 31, 2019
2018 -22.7 +63.7 +73.7% Jan 1, 2018 Dec 31, 2018
2017 -86.4 -8.61 -11.1% Jan 1, 2017 Dec 31, 2017
2016 -77.8 +25.8 +24.9% Jan 1, 2016 Dec 31, 2016
2015 -104 -92.7 -858% Jan 1, 2015 Dec 31, 2015
2014 -10.8 -0.08 -0.75% Jan 1, 2014 Dec 31, 2014
2013 -10.7 -4.81 -81.2% Jan 1, 2013 Dec 31, 2013
2012 -5.93 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.